|
Volumn 18, Issue 6, 2001, Pages 208-211
|
How large studies may mislead: The HOPE study
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTILIPEMIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CAPTOPRIL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENALAPRIL;
LISINOPRIL;
PLACEBO;
RAMIPRIL;
BLOOD PRESSURE;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL RESEARCH;
CLINICAL TRIAL;
DRUG EFFECT;
HEART FAILURE;
HIGH RISK PATIENT;
HUMAN;
HYPERTENSION;
INSULIN DEPENDENT DIABETES MELLITUS;
ISCHEMIC HEART DISEASE;
LASER;
MICROALBUMINURIA;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATIENT CODING;
PERIPHERAL VASCULAR DISEASE;
PROPHYLAXIS;
REVIEW;
RISK FACTOR;
STROKE;
TREATMENT OUTCOME;
UNSTABLE ANGINA PECTORIS;
|
EID: 0034870977
PISSN: 13578170
EISSN: None
Source Type: Journal
DOI: 10.1002/pdi.227 Document Type: Review |
Times cited : (4)
|
References (12)
|